The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 2.21
All Cancer Sites (Invasive)
United States Cancer Prevalence Estimates
Estimated United States Cancer Prevalence Counts a on January 1, 2014
By Race/Ethnicity, Sex and Years Since Diagnosis
WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are
NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.
| Race/Ethnicity | Sex | Years Since Diagnosis | Completeh | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 to <5 | 5 to <10 | 10 to <15 | 15 to <20 | 20 to <25 | 25 to <30 | 0 to <22e | 0 to <39e | >=39g | |||
| All Races b | Both Sexes | 4,811,335 | 3,458,926 | 2,487,009 | 1,607,842 | 979,134 | 572,214 | 13,168,343 | 14,407,575 | 331,144 | 14,738,719 |
| Males | 2,398,374 | 1,760,830 | 1,211,624 | 716,170 | 389,057 | 183,754 | 6,416,572 | 6,804,930 | 67,693 | 6,872,623 | |
| Females | 2,412,961 | 1,698,096 | 1,275,385 | 891,672 | 590,077 | 388,460 | 6,751,771 | 7,602,645 | 263,451 | 7,866,096 | |
| White b | Both Sexes | 4,023,367 | 2,962,254 | 2,170,661 | 1,417,248 | 879,656 | 518,734 | 11,293,349 | 12,418,373 | 288,481 | 12,706,854 |
| Males | 2,002,155 | 1,500,367 | 1,051,300 | 628,853 | 352,400 | 168,856 | 5,480,191 | 5,837,863 | 63,500 | 5,901,363 | |
| Females | 2,021,212 | 1,461,887 | 1,119,361 | 788,395 | 527,256 | 349,878 | 5,813,158 | 6,580,510 | 224,981 | 6,805,491 | |
| Black b | Both Sexes | 512,252 | 326,396 | 212,690 | 125,208 | 63,844 | 33,107 | 1,230,198 | 1,301,463 | 20,638 | 1,322,101 |
| Males | 265,247 | 178,106 | 114,764 | 61,405 | 24,687 | 8,967 | 641,281 | 659,527 | 1,614 | 661,141 | |
| Females | 247,005 | 148,290 | 97,926 | 63,803 | 39,157 | 24,140 | 588,917 | 641,936 | 19,024 | 660,960 | |
| Asian/ Pacific Islander c |
Both Sexes | 163,354 | 104,909 | 68,579 | 41,293 | + | + | 387,801 | + | + | + |
| Males | 66,872 | 43,218 | 26,311 | 14,086 | + | + | 153,629 | + | + | + | |
| Females | 96,482 | 61,691 | 42,268 | 27,207 | + | + | 234,172 | + | + | + | |
| Hispanic d | Both Sexes | 360,571 | 234,592 | 153,660 | 93,427 | + | + | 865,806 | + | + | + |
| Males | 164,021 | 109,492 | 68,272 | 38,406 | + | + | 389,118 | + | + | + | |
| Females | 196,550 | 125,100 | 85,388 | 55,021 | + | + | 476,688 | + | + | + | |
Estimated prevalence percent a on January 1, 2014, of the SEERc population diagnosed in the previous 22 years
By Age at Prevalence, Race/Ethnicity and Sex
WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are
NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.
| Race/Ethnicity | Sex | Age Specific (Crude) | Age-Adjustedf | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Ages | 0-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | 80+ | All Ages | ||
| All Races c | Both Sexes | 3.6726% | 0.0859% | 0.1918% | 0.3568% | 0.8240% | 2.0056% | 4.6050% | 9.8334% | 17.1858% | 20.0608% | 3.4366% |
| Males | 3.5781% | 0.0885% | 0.2024% | 0.3478% | 0.6534% | 1.3766% | 3.6863% | 10.1455% | 21.1175% | 27.7173% | 3.7334% | |
| Females | 3.7649% | 0.0832% | 0.1808% | 0.3662% | 0.9961% | 2.6288% | 5.4871% | 9.5517% | 13.9675% | 15.4474% | 3.2830% | |
| White c | Both Sexes | 4.0665% | 0.0929% | 0.2108% | 0.4063% | 0.9283% | 2.1632% | 4.8293% | 10.2825% | 18.1910% | 21.1239% | 3.6387% |
| Males | 3.9322% | 0.0947% | 0.2229% | 0.3990% | 0.7455% | 1.5103% | 3.8325% | 10.4111% | 21.9237% | 28.6276% | 3.8915% | |
| Females | 4.2003% | 0.0910% | 0.1981% | 0.4142% | 1.1209% | 2.8389% | 5.8188% | 10.1621% | 15.0517% | 16.5393% | 3.5245% | |
| Black c | Both Sexes | 2.7570% | 0.0667% | 0.1364% | 0.2260% | 0.5605% | 1.6357% | 4.3487% | 10.2399% | 17.0707% | 17.5782% | 3.2346% |
| Males | 2.9887% | 0.0698% | 0.1395% | 0.2172% | 0.4110% | 1.1550% | 4.1546% | 12.8883% | 24.8996% | 29.2823% | 4.1795% | |
| Females | 2.5457% | 0.0635% | 0.1332% | 0.2346% | 0.6924% | 2.0569% | 4.5183% | 8.1676% | 11.6193% | 11.7790% | 2.6610% | |
| Asian/ Pacific Islander c |
Both Sexes | 2.3212% | 0.0657% | 0.1414% | 0.2206% | 0.5032% | 1.4265% | 3.2873% | 6.2783% | 10.3231% | 13.4483% | 2.2360% |
| Males | 1.9548% | 0.0706% | 0.1490% | 0.2038% | 0.3371% | 0.7341% | 2.0281% | 5.3728% | 11.6467% | 18.1039% | 2.1377% | |
| Females | 2.6577% | 0.0606% | 0.1335% | 0.2377% | 0.6543% | 2.0388% | 4.3723% | 7.0195% | 9.2902% | 10.5876% | 2.3681% | |
| Hispanic d | Both Sexes | 1.6302% | 0.0792% | 0.1831% | 0.2931% | 0.6247% | 1.4179% | 3.2774% | 6.9661% | 12.2766% | 14.5657% | 2.4873% |
| Males | 1.4427% | 0.0820% | 0.1948% | 0.2973% | 0.4845% | 0.8960% | 2.3041% | 6.7216% | 15.4395% | 21.0468% | 2.6791% | |
| Females | 1.8206% | 0.0762% | 0.1711% | 0.2884% | 0.7740% | 1.9601% | 4.2201% | 7.1779% | 9.9162% | 10.6486% | 2.4322% | |
Footnotes:
a US 2014 cancer prevalence counts are based on 2014 cancer prevalence proportions from the SEER registries and 1/1/2014 US population estimates based on the average of 2013 and 2014 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 39/22 years.
b Statistics based on SEER 9 Areas.
c Statistics based on SEER 13 Areas excluding the Alaska Native Registry
d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.
e Maximum limited-duration prevalence: 39 years for 1975-2014 SEER 9 data; 22 years for 1992-2014 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.
f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.
g Cases diagnosed more than 39 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).
h Complete prevalence is obtained by summing 0 to <39 and >=39.
i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.
- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.
+ Not available.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.